1. Adherence to iron chelation therapy and associated healthcare resource utilization and costs in Medicaid patients with sickle cell disease and thalassemia. (3rd March 2016) Authors: Vekeman, Francis; Sasane, Medha; Cheng, Wendy Y; Ramanakumar, Agnihotram V.; Fortier, Jonathan; Qiu, Ying; Duh, Mei Sheng; Paley, Carole; Adams-Graves, Patricia Journal: Journal of medical economics Issue: Volume 19:Number 3(2016) Page Start: 292 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Age‐related treatment patterns in sickle cell disease patients and the associated sickle cell complications and healthcare costs1. Issue 5 (17th January 2013) Authors: Blinder, Morey A.; Vekeman, Francis; Sasane, Medha; Trahey, Alex; Paley, Carole; Duh, Mei Sheng Journal: Pediatric blood & cancer Issue: Volume 60:Issue 5(2013:May) Page Start: 828 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. ALK rearrangement testing and treatment patterns for patients with ALK-positive non-small cell lung cancer. Issue 3 (June 2015) Authors: Guérin, Annie; Sasane, Medha; Zhang, Jie; Macalalad, Alexander R.; Galebach, Philip; Jarvis, John; Kageleiry, Andrew; Culver, Kenneth; Wu, Eric Q.; Wakelee, Heather Journal: Cancer epidemiology Issue: Volume 39:Issue 3(2015) Page Start: 307 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Brain metastases in patients with ALK+ non-small cell lung cancer: clinical symptoms, treatment patterns and economic burden. (April 2015) Authors: Guérin, Annie; Sasane, Medha; Zhang, Jie; Culver, Kenneth W.; Dea, Katherine; Nitulescu, Roy; Wu, Eric Qiong Journal: Journal of medical economics Issue: Volume 18:Number 4(2015) Page Start: 312 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Characteristics, treatment patterns, and survival among ALK+ non-small cell lung cancer (NSCLC) patients treated with crizotinib: A chart review study. (August 2016) Authors: Cadranel, Jacques; Park, Keunchil; Arrieta, Oscar; Pless, Miklos; Bendaly, Edmond; Patel, Dony; Sasane, Medha; Nosal, Adam; Swallow, Elyse; Galebach, Philip; Kageleiry, Andrew; Stein, Karen; Degun, Ravi; Zhang, Jie Journal: Lung cancer Issue: Volume 98(2016) Page Start: 9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Characteristics, treatment patterns, and survival among ALK+ non-small cell lung cancer (NSCLC) patients treated with crizotinib: A chart review study. (August 2016) Authors: Cadranel, Jacques; Park, Keunchil; Arrieta, Oscar; Pless, Miklos; Bendaly, Edmond; Patel, Dony; Sasane, Medha; Nosal, Adam; Swallow, Elyse; Galebach, Philip; Kageleiry, Andrew; Stein, Karen; Degun, Ravi; Zhang, Jie Journal: Lung cancer Issue: Volume 98(2016) Page Start: 9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Deferasirox therapy is associated with reduced mortality risk in a medicare population with myelodysplastic syndromes. (August 2015) Authors: Zeidan, Amer M; Hendrick, Franklin; Friedmann, Erika; Baer, Maria R; Gore, Steven D; Sasane, Medha; Paley, Carole; Davidoff, Amy J Journal: Journal of comparative effectiveness research Issue: Volume 4:Number 4(2015) Page Start: 327 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Deferasirox therapy is associated with reduced mortality risk in a medicare population with myelodysplastic syndromes. (August 2015) Authors: Zeidan, Amer M; Hendrick, Franklin; Friedmann, Erika; Baer, Maria R; Gore, Steven D; Sasane, Medha; Paley, Carole; Davidoff, Amy J Journal: Journal of comparative effectiveness research Issue: Volume 4:Number 4(2015) Page Start: 327 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Epidemiologic and clinical characteristics of nontransfusion‐dependent thalassemia in the United States. Issue 7 (10th April 2018) Authors: Vichinsky, Elliott; Cohen, Alan; Thompson, Alexis A.; Giardina, Patricia J.; Lal, Ashutosh; Paley, Carole; Cheng, Wendy Y.; McCormick, Nora; Sasane, Medha; Qiu, Ying; Kwiatkowski, Janet L. Journal: Pediatric blood & cancer Issue: Volume 65:Issue 7(2018) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Is time to progression associated with post-progression survival in previously treated metastatic non-small cell lung cancer with BRAF V600E mutation? A secondary analysis of phase II clinical trial data. Issue 8 (17th August 2018) Authors: Li, Junlong; Sasane, Medha; Zhang, Jie; Zhao, Jing; Ricculli, Marie Louise; Yao, Zhiwen; Redhu, Suman; Signorovitch, James Journal: BMJ open Issue: Volume 8:Issue 8(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗